Document Preview Unavailable

Inhibitory effects of icotinib combined with antiangiogenic drugs in human non‐small cell lung cancer xenograft models are better than single target drugs

Jiang, Peng; Zhang, Yan; Cui, Jiadong; Wang, Xiuxiu; Li, Yu.  Thoracic Cancer Vol. 13, Iss. 2,  (Jan 2022): 257-264.

You might have access to this document